✦ LIBER ✦

No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran

✍ Scribed by Dr Troy C. Sarich, Renli Teng, Gary R. Peters, Maria Wollbratt, Robert Homolka, Mia Svensson, Ulf G. Eriksson

Book ID: 119926487
Publisher: Springer International Publishing AG
Year: 2003
Tongue: English
Weight: 124 KB
Volume: 42
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200342050-00006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid

✍ Gunnar Fager; Marie Cullberg; Maria Eriksson-Lepkowska; Lars Frison; Ulf G. Erik 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 311 KB

The pharmacodynamics and pharmacokinetic

The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review

✍ David Gustafsson; Margareta Elg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Influence of Age on the Pharmacokinetics

Influence of Age on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor

✍ Linda C. Johansson, Lars Frison, Ulrika Logren, Gunnar Fager, David Gustafsson, 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 157 KB

No Influence of Ethnic Origin on the Pha

No Influence of Ethnic Origin on the Pharmacokinetics and Pharmacodynamics of Melagatran Following Oral Administration of Ximelagatran, a Novel Oral Direct Thrombin Inhibitor, to Healthy Male Volunteers

✍ Linda C. Johansson, Magnus Andersson, Gunnar Fager, David Gustafsson, Dr Ulf G. 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 156 KB

Comparable Pharmacokinetics and Pharmaco

Comparable Pharmacokinetics and Pharmacodynamics of Melagatran in Japanese and Caucasian Volunteers after Oral Administration of the Direct Thrombin Inhibitor Ximelagatran

✍ Dr Linda C. Wernevik, Per Nyström, Magnus Andersson, Gillis Johnsson, Anders Byl 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 213 KB

No Influence of Mild-To-Moderate Hepatic

No Influence of Mild-To-Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor

✍ Dr Karin Wåhlander, Maria Eriksson-Lepkowska, Lars Frison… 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 131 KB